ABL Bio Inc. (KOSDAQ:298380)
South Korea flag South Korea · Delayed Price · Currency is KRW
173,400
+7,400 (4.46%)
At close: Nov 26, 2025

ABL Bio Revenue

ABL Bio had revenue of 1.44B KRW in the quarter ending September 30, 2025, a decrease of -81.82%. This brings the company's revenue in the last twelve months to 88.44B, up 173.62% year-over-year. In the year 2024, ABL Bio had annual revenue of 33.40B, down -49.04%.

Revenue (ttm)
88.44B
Revenue Growth
+173.62%
P/S Ratio
108.09
Revenue / Employee
867.02M
Employees
102
Market Cap
9.56T

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202433.40B-32.14B-49.04%
Dec 31, 202365.55B-1.75B-2.61%
Dec 31, 202267.30B61.97B1,162.19%
Dec 31, 20215.33B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition